General Biologicals Corporation (TPEX:4117)
12.70
-0.90 (-6.62%)
Jun 18, 2026, 2:59 PM CST
-33.68% (1Y)
| Market Cap | 772.48M -35.4% |
| Revenue (ttm) | 215.74M -14.4% |
| Net Income | 465.84M |
| EPS | 7.44 |
| Shares Out | 60.83M |
| PE Ratio | 1.71 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 609,004 |
| Open | 13.50 |
| Previous Close | 13.60 |
| Day's Range | 12.35 - 14.05 |
| 52-Week Range | 3.50 - 19.10 |
| Beta | 0.85 |
| Analysts | Buy |
| Price Target | 38.00 (+199.21%) |
| Earnings Date | Aug 12, 2026 |